These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16475491)

  • 21. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual form of cutaneous leishmaniasis: erysipeloid form.
    Mnejja M; Hammami B; Chakroun A; Achour I; Charfeddine I; Chakroun A; Turki H; Ghorbel A
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):95-7. PubMed ID: 21251895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood and adult cutaneous leishmaniasis in Tunisia.
    Zaraa I; Ishak F; Kort R; El Euch D; Mokni M; Chaker E; Ben Osman A
    Int J Dermatol; 2010 Jul; 49(7):790-3. PubMed ID: 20618499
    [No Abstract]   [Full Text] [Related]  

  • 24. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
    Noguera-Morel L; Azorin D; Xirotagaros G
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
    Masood S; Naveed S; Alvi RU
    Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
    Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
    Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmaniasis of the Feet Sole: A Case Report.
    Ayatollahi J; Bafghi AF; Shahcheraghi SH
    Turkiye Parazitol Derg; 2017 Mar; 41(1):48-49. PubMed ID: 28483734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
    El kartouti A; Elbenaye J; Miloudi M
    Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B; Abbaszadeh B; Khamesipour A
    Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.
    Kashani MN; Firooz A; Eskandari SE; Ghoorchi MH; Khamesipour A; Khatami A; Javadi A; Dowlati Y
    Eur J Dermatol; 2007; 17(6):513-5. PubMed ID: 17951131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasiform cutaneous leishmaniasis.
    Veraldi S; Galloni C; Cremonesi R; Cavalli R
    Int J Dermatol; 2006 Feb; 45(2):129-30. PubMed ID: 16445503
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous leishmaniasis mimicking granulomatous cheilitis and treated successfully with oral fluconazole in a boy.
    Serarslan G; Aksakal M
    Ann Parasitol; 2015; 61(3):197-9. PubMed ID: 26568994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonhealing ulcers: an infectious viewpoint.
    Shahlaee A; Jazayeri SB
    Mayo Clin Proc; 2014 Jan; 89(1):e5-6. PubMed ID: 24388036
    [No Abstract]   [Full Text] [Related]  

  • 39. Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.
    Sgarbi IM; Santos FD; Monteiro VE; Fonseca SN; Bernardes Filho F
    Braz J Infect Dis; 2017; 21(2):201-202. PubMed ID: 28012931
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G; Nilfroushzadeh MA; Iraji F
    Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.